The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2165 participants.

Also called NCT01608724

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,165 participants (enrolled count) (from the registry)
Sponsor
  • AstraZeneca Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01608724
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01608724. Non-randomized; no masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2014-05 (actual). Results posted on 2016-02-02.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
Acronym
SUNSHINE
Condition
Diabetes Mellitus, Non-Insulin-Dependent
Intervention (Drug)
Saxagliptin
Lead sponsor
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct01608724
Content hash
8b3f6e08032ebd5d4730ea90f43f557e049d2297f5e80562bc2cf632272800ee